查看购物车
  • Traditional Chinese
  • English
  • Japanese
全球多菌株益生菌市场 - 2023-2030
市场调查报告书
商品编码
1359943

全球多菌株益生菌市场 - 2023-2030

Global Multistrain Probiotics Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述 ：

2022年，全球多菌株益生菌市场达到730亿美元，预计2030年将达到1,371亿美元，2023-2030年预测期间复合年增长率为8.2%。

多菌株益生菌中存在多种细菌菌株。经常食用可以使肠道保持健康状态。由于它是一种安全产品，可以针对疾病和传染源提供治疗和保护屏障，因此多菌株益生菌的使用越来越受欢迎。由于不同菌株之间的协同作用和累加效应，多菌株益生菌也比单菌株益生菌更健康。

多菌株益生菌市场可能在未来几年保持成长势头，因为它们具有更广泛的功效和协同效应。此外，由于人们越来越了解多菌株益生菌对免疫、消化系统和整体健康的影响，因此对多菌株益生菌的需求不断增加。领先的益生菌製造商正在利用消费者可支配收入的增加和饮食意识的提高，努力提高其各种多菌株益生菌的销售利润。

亚太地区主导全球多菌株益生菌市场，2022 年收入份额为 46.5%。亚太地区多菌株益生菌市场受到不断增长的消费者需求、媒体关注和新技术意识的推动。中国和印度益生菌意识的不断增强预计将加速该地区市场的成长。

动态：

提高健康意识

随着消费者肠道健康意识的增强，对多菌株益生菌的需求预计将会增加。随着保持健康的肠道对消费者变得越来越重要，近年来，主要参与者积极提供益生菌食品、饮料和补充剂。随着越来越多的消费者接受肠道健康与身体健康、体重管理和能量维持之间的联繫，预计未来几年益生菌的需求将会增加。健康饮食趋势的兴起以及人们对营养对健康影响的认识不断增强，促使製造商生产和销售具有特定健康声明的食品。西方市场的消费者对健康生活采取全面的态度，益生菌的消费量正在增加。

为了向消费者提供高品质的益生菌产品，製造商正在尝试添加免疫益处的益生菌的配方和生产。多菌株配方、菌株特异性製剂等方面的工作正在进行中。例如，益生菌饮料和补充剂公司 GoodBellyProbiotics 于 2022 年 8 月推出了新的免疫支持产品线，其中包括夸脱饮料和注射。 GoodBellyImmune Support Shots 的凤梨、百香果、柠檬、生姜和姜黄口味含有与夸脱相同的益生菌菌株。

国际组织参与益生菌产品研发

多菌株益生菌对人类和动物的健康优势在全球范围内得到认可。世界卫生组织、IPA 以及国际益生菌和益生元科学协会等国际组织正在提高人们对益生菌的认识，因为益生菌的益处越来越多。益生菌研发的监管和投资政策由协会与各国政府合作制定，推动了多菌株益生菌市场的发展。此外，益生菌研究也取得了重大进展，提高了人们对各种菌株的作用及其潜在健康优势的了解。益生菌产业越来越有兴趣利用科学进步来创造具有特定特征和功能的菌株。

开发新益生菌菌株的研发成本高昂

多菌株益生菌市场的发展受到研发活动、实验室、研究设备的大量投资以及僱用合格员工的高成本的阻碍。益生菌菌株和产品的开发和生产遵循国际食品法规。由于生产成本高，所以成品价格也高。不同的分销管道用于行销和分销益生菌产品。它们也有各种包装。因此，这些因素提高了产品的成本，使其变得更加昂贵，进而抑制了消费者的购买行为，为产业参与者带来了挑战。

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 按应用程式片段
  • 最终使用者的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 提高健康意识
      • 国际组织参与益生菌产品研发
    • 限制
      • 开发新益生菌菌株的研发成本较高
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • 俄乌战争影响分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：按应用

  • 食品和饮料
  • 动物饲料
  • 膳食补充剂

第 8 章：最终用户

  • 人类
  • 动物

第 9 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

    • 养乐多本社株式会社
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • 鹿兰酶公司
  • 蛋白质
  • 丹尼斯克
  • 盖亚生物
  • 科。汉森
  • 达弗龙有限公司
  • 拉勒曼德公司
  • 普罗比公司
  • Innovix Labs 清单并非详尽无遗

第 12 章：附录

简介目录
Product Code: FB6995

Overview:

Global Multistrain Probiotics Market reached US$ 73 billion in 2022 and is expected to reach US$ 137.1 billion by 2030, growing with a CAGR of 8.2% during the forecast period 2023-2030.

Multiple bacterial strains are present in multistrain probiotics. Regular consumption keeps the gut in a healthy state. Because it is a safe product that provides a therapeutic and protective barrier against diseases and infectious agents, the use of multistrain probiotics is growing in popularity. Due to the synergy and additive effects between the various isolates, multistrain probiotics are also significantly healthier than single-strain probiotics.

The market for multistrain probiotics is likely to maintain its momentum in the coming years because they suggest a wider spectrum of efficacy and synergistic effects. In addition, there is a rising need for multistrain probiotics due to growing knowledge about their effects on immunity, the digestive system, and overall wellness. Leading probiotics manufacturers are working to increase the profitability of sales of their wide range of multistrain probiotics by taking advantage of consumers' rising disposable income and increasing dietary awareness.

Asia Pacific dominated the global multistrain probiotics market with revenue share of 46.5% in the year 2022. The Asia-Pacific multistrain probiotics market is driven by rising consumer demand, media attention, and awareness of new technology. Growing probiotic awareness in China and India is anticipated to accelerate the growth of the regional market.

Dynamics:

Increasing Awareness About Health

The demand for multistrain probiotics is anticipated to increase as consumer awareness of gut health increases. As maintaining a healthy gut becomes more crucial to consumers, major players have actively offered probiotic food, drinks, and supplements in recent years. Probiotic demand is anticipated to rise in the coming years as more consumers accept the connection between gut health and physical health, weight management, and energy maintenance. The production and marketing of food with specific health claims by manufacturers is prompted by rising trends towards healthier diets and growing awareness of the impact of nutrition on health. Western markets, where consumers adopt a holistic approach to healthy living, are seeing an increase in probiotic consumption.

To provide consumers with high-quality probiotic products, manufacturers are experimenting with the formulation and production of probiotics with the added immunity benefits. Work is being done on multi-strain formulations, strain-specific formations, etc. For instance, the probiotic beverage and supplement company GoodBellyProbiotics unveiled its new Immune Support product line in August 2022, which includes quart beverages and shots. The pineapple, passionfruit, lemon, ginger, and turmeric flavours of the GoodBellyImmune Support Shots contain the same probiotic strains that the quarts do.

International Organisations' Involvement in Probiotic Products Research and Development

The health advantages of multistrain probiotics for both humans and animals are acknowledged on a global scale. International organisations like the WHO, IPA, and the International Scientific Association for Probiotics and Prebiotics are raising awareness about probiotics due to their growing benefits. The regulation and investment policies for probiotic R&D are drafted by associations in collaboration with national governments, which in turn drives the multistrain probiotics market. Additionally, there have been significant advancements in probiotic research, which have improved the understanding of the workings of various strains and their potential health advantages. The probiotic industry is increasingly interested in using scientific advancements to create strains with particular characteristics and capabilities.

High R&D Costs for Developing New Probiotic Strains

The development of the multistrain probiotics market is hindered by significant investments in R&D activities, laboratories, research equipment, and the high cost of hiring qualified employees. International food regulations are followed in the development and production of probiotic strains and products. Due to the high cost of production, the price of the finished product is high. Different channels of distribution are used for marketing and distributing probiotic products. They come in various packaging as well. Thus, these factors raise the cost of the product, making it more expensive, which in turn restrains consumer purchasing behaviour and presents a challenge for industry players.

Segment Analysis:

The global multistrain probiotics market is segmented based on application, end-user and region.

Enzymes and Probiotics are Being Added to Food and Beverage Products by Manufacturers More Frequently

The segment is anticipated to grow as a result of rising consumer demand for food products with higher nutrient and fibre contents. Probiotics and other digestive ingredients are frequently used in fish oil and yoghurt to lower the risk of issues with gut health. Probiotics have become more popular among consumers as a remedy for their health problems as a result of rising disposable incomes and a growing awareness of ways to improve quality of life. Due to the rising demand for probiotics in foods and drinks, manufacturers are growing their operations. For instance, Korea's Hy Co, formerly known as Korea Yakult, announced in August 2022 that it would be expanding into probiotic business categories to offer a wider range of products.

Geographical Penetration:

In Asia Pacific, Disposable Incomes are Rising, Standards of Living are Rising, and Acceptance of Functional Foods is Growing

Due to growing awareness of fitness and maintaining good digestive health, consumers in this region are becoming more and more interested in healthy products. In addition, there is a growing market for products that support a healthy gut microbiome due to the growing significance of gut health in overall wellbeing. Multistrain probiotic supplements are becoming more and more well-liked among the region's health-conscious consumers because they are thought to be an easy and efficient way to add beneficial bacteria to the gut. The demand for multistrain probiotics in infant formula has been extremely high in China and is expected to continue to rise over the next few years. Due to an ageing population, a growing awareness of the value of preventive healthcare, and numerous studies demonstrating the advantages of these products for immunity, cognitive health, and skincare, the market in Asia Pacific has experienced significant growth.

COVID-19 Impact Analysis:

The COVID-19 pandemic has increased understanding of the value of a robust immune system. To support their immune systems, many consumers have turned to dietary supplements, such as multistrain probiotics. The marketing of some multistrain probiotics as immune-boosters has increased demand. Furthermore, the significance of overall health and wellness has been emphasised by COVID-19. Customers are more likely to spend money on products that support overall health, which includes gut health. Multistrain probiotics have benefited from this development because of their potential to support immune and digestive health.

Russia-Ukraine War Impact Analysis:

Supply chains were disrupted by geopolitical tensions and economic sanctions, which had an impact on where raw materials were sourced and how multistrain probiotics were produced. Supply issues result from suppliers or manufacturers being situated in regions that are directly impacted by the conflict. Additionally, the economic unpredictability brought on by the war caused some consumers to cut back on discretionary spending, including on dietary supplements. The sales of multistrain probiotics were impacted by this.

By Application

  • Food and Beverages
  • Animal Feed
  • Dietary Supplements

By End-User

  • Humans
  • Animals

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In March 2023, The FX-856 strain, which lessens the symptoms of diarrhoea, constipation, bloating, and ulcerative colitis, was introduced by the English pharmaceutical company FERRYX Ltd.
  • In May 2023, Roquette unveiled PEARLITOL ProTec, a cutting-edge excipient made with the intention of improving the stability of probiotic supplements.
  • In April 2023, an improved quality specification for the well-known probiotic bacteria LifeinU L. Rhamnosus GG was introduced by Lesaffre's Gnosis.

Competitive Landscape

The major global players in the market: Yakult Honsha Co., Ltd., Deerland Enzymes, Inc., Protexin, Danisco, BioGaia, Chr. Hansen, Daflorn Ltd., Lallemand Inc., Probi AB and Innovix Labs.

Why Purchase the Report?

  • To visualize the global multistrain probiotics market segmentation based on application, end-user, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of multistrain probiotics market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global multistrain probiotics market report would provide approximately 53 tables, 46 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Application
  • 3.2. Snippet by End-User
  • 3.3. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Awareness About Health
      • 4.1.1.2. International Organisations' Involvement in Probiotic Products Research and Development
    • 4.1.2. Restraints
      • 4.1.2.1. High R&D Costs for Developing New Probiotic Strains
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Russia-Ukraine War Impact Analysis
  • 5.6. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Food and Beverages*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Animal Feed
  • 7.4. Dietary Supplements

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Humans*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Animal

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

    • 11.1.1. Yakult Honsha Co., Ltd.*
    • 11.1.2. Company Overview
    • 11.1.3. Product Portfolio and Description
    • 11.1.4. Financial Overview
    • 11.1.5. Key Developments
  • 11.2. Deerland Enzymes, Inc.
  • 11.3. Protexin
  • 11.4. Danisco
  • 11.5. BioGaia
  • 11.6. Chr. Hansen
  • 11.7. Daflorn Ltd.
  • 11.8. Lallemand Inc.
  • 11.9. Probi AB
  • 11.10. Innovix Labs LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us